Manufacturer's investigation conclusion: a direct correlation between heartmate (hm) 3 left ventricular assist system (lvas), serial number (b)(4), and the reported events could not be conclusively determined through this evaluation.Multiple attempts were made to obtain additional information from the customer regarding the event; however, no additional information was provided.The patient remains ongoing on hm3 lvas, serial number (b)(4), and no further events have been reported at this time.The heartmate 3 lvas ifu, rev.C, is currently available.The ifu, ¿introduction¿, lists potential adverse events, including cardiac arrhythmia and right heart failure, that may be associated with the use of the heartmate 3 left ventricular assist system.The ifu, ¿patient care and management¿, lists arrhythmia as a potential late postimplant complication.The relevant sections of the device history records for (b)(4) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on 26apr2022.No further information was provided.The manufacturer is closing the file on this event.
|
It was reported that the patient fibrillated and was cardioverted during surgery.The arrhythmia occurred after sternotomy but prior to device implant.Cardiopulmonary bypass (cpb) was initiated before further manipulation of the left ventricle due to the patient's history of ventricular tachycardia (vt) and irritable myocardium.Following left ventricular assist device (lvad) implant the patient was cardioverted three times due to vt.Lvad speed was decreased, cardiac resynchronization therapy defibrillator (crtd) was interrogated, and an amiodarone bolus was given.Of note, the patient had a history of ventricular tachycardia, atrial fibrillation and atrial flutter prior to implant.Additional information was received that a chest x-ray on 21may2022 showed bilateral pleural effusions and probable atelectasis.A swallow study showed mild dysphagia due to weakness from debility and intubation.It was noted that the patient had a history of pulmonary hypertension and right side lung cancer.Post radiation the patient was having increased oxygen demands.It was also noted that as of (b)(6) 2022, the patient remained on inotropes since lvad placement, indicating right heart failure.
|